Skip to main content

Advertisement

Log in

Association between ABO gene polymorphism (rs505922) and cancer risk: a meta-analysis

Tumor Biology

Abstract

Previous studies have showed that ABO blood type is associated with multiple gastrointestinal cancers, including pancreatic cancer. Recently, one single nucleotide polymorphism (SNP) rs505922 in ABO gene has been implicated in susceptibility to pancreatic cancer across different populations, but different results were found in other types of cancer. This meta-analysis aimed to clarify the association. All eligible case–control studies were identified by searching through PubMed and Chinese language databases (CNKI and WanFang) up to September 1, 2014. Pooled estimates (odds ratio) were used to assess the strength of associations in fixed- or random-effects models. A total of nine studies with 10,304 cases and 15,564 controls were included. Overall, SNP rs505922 C allele was confirmed as a risk factor for cancer. Additionally, in further stratified analysis by cancer type, C allele carriers were more likely to have higher risk of pancreatic cancer. This study provided evidence of SNP rs505922 C allele as a strong risk factor of cancer susceptibility, specifically for pancreatic cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solo mon RZ, Jacobs KB, et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet. 2010;42:224–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, et al. Genome-wide association study identifies variants in the abo locus associated with susceptibility to pancreatic cancer. Nat Genet. 2009;41:986–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Reid ME, Mohandas N. Red blood cell blood group antigens: structure and function. Semin Hematol. 2004;41:93–117.

    Article  CAS  PubMed  Google Scholar 

  4. Aird I, Bentall HH, Roberts JA. A relationship between cancer of stomach and the ABO blood groups. Br Med J. 1953;1:799–801.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Aird I, Lee DR, Roberts JA. ABO blood groups and cancer of oesophagus, cancerof pancreas, and pituitary adenoma. Br Med J. 1960;1:1163–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Melzer D, Perry JR, Hernandez D, Corsi AM, Stevens K, Rafferty I, et al. A genome-wide association study identifies protein quantitative trait loci (pqtls). PLoS Genet. 2008;4:e1000072.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Liumbruno GM, Franchini M. Hemostasis, cancer, and abo blood group: the most recent evidence of association. J Thromb Thrombolysis. 2014;38:160–6.

    Article  CAS  PubMed  Google Scholar 

  8. Pare G, Chasman DI, Kellogg M, Zee RY, Rifai N, Badola S, et al. Novel association of abo histo-blood group antigen with soluble icam-1: results of a genome-wide association study of 6,578 women. PLoS Genet. 2008;4:e1000118.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Yuan X, Waterworth D, Perry JR, Lim N, Song K, Chambers JC, et al. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am J Hum Genet. 2008;83:520–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Souto JC, Almasy L, Muniz-Diaz E, Soria JM, Borrell M, Bayen L, et al. Functional effects of the abo locus polymorphism on plasma levels of von willebrand factor, factor VIII, and activated partial thromboplastin time. Arterioscler Thromb Vasc Biol. 2000;20:2024–8.

    Article  CAS  PubMed  Google Scholar 

  11. Itzkowitz SH, Yuan M, Ferrell LD, Ratcliffe RM, Chung YS, Satake K, et al. Cancer-associated alterations of blood group antigen expression in the human pancreas. J Natl Cancer Inst. 1987;79:425–34.

    CAS  PubMed  Google Scholar 

  12. Ishijima N, Suzuki M, Ashida H, Ichikawa Y, Kanegae Y, Saito I, et al. Baba-mediated adherence is a potentiator of the helicobacter pylori type iv secretion system activity. J Biol Chem. 2011;286:25256–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Trikudanathan G, Philip A, Dasanu CA, Baker WL. Association between helicobacter pylori infection and pancreatic cancer. A cumulative meta-analysis. JOP. 2011;12:26–31.

    PubMed  Google Scholar 

  14. Wang DS, Chen DL, Ren C, Wang ZQ, Qiu MZ, Luo HY, et al. ABO blood group, hepatitis b viral infection and risk of pancreatic cancer. Int J Cancer J Int Cancer. 2012;131:461–8.

    Article  CAS  Google Scholar 

  15. Duell EJ, Bonet C, Munoz X, Lujan-Barroso L, Weiderpass E, Boutron-Ruault MC, Racine A, Severi G, Canzian F, Rizzato C, Boeing H, Overvad K, Tjonneland A, Arguelles M, Sanchez-Cantalejo E, Chamosa S, Huerta JM, Barricarte A, Khaw KT, Wareham N, Travis RC, Trichopoulou A, Trichopoulos D, Yiannakouris N, Palli D, Agnoli C, Tumino R, Naccarati A, Panico S, Bueno-de-Mesquita HB, Siersema PD, Peeters PH, Ohlsson B, Lindkvist B, Johansson I, Ye W, Johansson M, Fenger C, Riboli E, Sala N, Gonzalez CA. Variation at abo histo-blood group and FUT loci and diffuse and intestinal gastric cancer risk in a european population. Int J Cancer J Int Cancer. 2014;136(4):880-93.

  16. Gates MA, Xu M, Chen WY, Kraft P, Hankinson SE, Wolpin BM. ABO blood group and breast cancer incidence and survival. Int J Cancer J Int Cancer. 2012;130:2129–37.

    Article  CAS  Google Scholar 

  17. Krawczyk M, Mihalache F, Hoblinger A, Acalovschi M, Lammert F, Zimmer V. Pancreatic cancer risk variant abo rs505922 in patients with cholangiocarcinoma. World J Gastroenterol WJG. 2011;17:4640–2.

    Article  CAS  PubMed  Google Scholar 

  18. Poole EM, Gates MA, High BA, Chanock SJ, Cramer DW, Cunningham JM, et al. ABO blood group and risk of epithelial ovarian cancer within the ovarian cancer association consortium. Cancer Causes Control CCC. 2012;23:1805–10.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Rizzato C, Campa D, Pezzilli R, Soucek P, Greenhalf W, Capurso G, et al. ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium. Oncol Rep. 2013;29:1637–44.

    CAS  PubMed  Google Scholar 

  20. Willis JA, Olson SH, Orlow I, Mukherjee S, McWilliams RR, Kurtz RC, et al. A replication study and genome-wide scan of single-nucleotide polymorphisms associated with pancreatic cancer risk and overall survival. Clin Cancer Research Off J Am Assoc Cancer Res. 2012;18:3942–51.

    Article  CAS  Google Scholar 

  21. Wolpin BM, Kraft P, Gross M, Helzlsouer K, Bueno-de-Mesquita HB, Steplowski E, et al. Pancreatic cancer risk and abo blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res. 2010;70:1015–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Xu HL, Cheng JR, Zhang W, Wang J, Yu H, et al. Re-evaluation of ABO gene polymorphisms detected in a genome-wide association study and risk of pancreatic ductal adenocarcinoma in a Chinese population. Chin J Cancer. 2014;33:68–73.

  23. Duell EJ, Bonet C, Munoz X, Lujan-Barroso L, Weiderpass E, et al. Variation at ABO histo-blood group and FUT loci and diffuse and intestinal gastric cancer risk in a European population. Int J Cancer. 2014;136(4):880–893.

  24. Gates MA, Xu M, Chen WY, Kraft P, Hankinson SE, et al. ABO blood group and breast cancer incidence and survival. Int J Cancer. 2012;130:2129–2137.

  25. Krawczyk M, Mihalache F, Hoblinger A, Acalovschi M, Lammert F, et al. Pancreatic cancer risk variant ABO rs505922 in patients with cholangiocarcinoma. World J Gastroenterol. 2011;17:4640–4642.

  26. Poole EM, Gates MA, High BA, Chanock SJ, Cramer DW, et al. ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium. Cancer Causes Control. 2012;23:1805–1810.

  27. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;127:820–826.

  28. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–1558.

  29. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–748.

  30. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188.

  31. Begg CB, Mazumdar M.(1994) Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–1101.

  32. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634.

  33. Rizzato C, Campa D, Pezzilli R, Soucek P, Greenhalf W, et al. ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium. Oncol Rep. 2013;29:1637–1644.

  34. Willis JA, Olson SH, Orlow I, Mukherjee S, McWilliams RR, et al. A replication study and genomewide scan of single-nucleotide polymorphisms associated with pancreatic cancer risk and overall survival. Clin Cancer Res. 2012;18:3942–3951.

  35. Wolpin BM, Kraft P, Gross M, Helzlsouer K, Bueno-de-Mesquita HB, et al. Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res. 2010;70:1015–1023.

Download references

Acknowledgments

This work was funded by grants from the Jiangsu Health International Exchange Supporting Program provided by Xiao-Dong Li.

Conflicts of interest

None.

Authors’ contributions

YFD, FZ, and XDL carried out the literature collection and screening. YFD, FZ, XDL, YA, and HZ participated in the design of the study and performed the meta-analysis. YFD, FZ, and XDL drafted the manuscript. YZ and XZ helped to edit the manuscript. YJ conceived of the study and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yong Jiang.

Additional information

Drs. Yun-Fei Duan, Feng Zhu, and Xiao-Dong Li contributed equally to this article and share the first authorship.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Duan, YF., Zhu, F., Li, XD. et al. Association between ABO gene polymorphism (rs505922) and cancer risk: a meta-analysis. Tumor Biol. 36, 5081–5087 (2015). https://doi.org/10.1007/s13277-015-3159-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-015-3159-y

Keywords

Navigation